Dr. David Bernstein, MD

Dr. Bernstein practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Bernstein's NPI, 1912078304, was assigned on November 10, 2006. Dr. Bernstein graduated from Renaissance School of Medicine at Stony Brook University in 1988. Dr. Bernstein holds New York license 178915.

Dr. Bernstein's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Bernstein's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Bernstein is also affiliated with Tisch Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Bernstein to 3 more medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernstein practices, 2 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Bernstein's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Bernstein is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bernstein's licenses on file in 2 states: New York and North Dakota.

Dmand AI lists acid reflux, cirrhosis of the liver, fatty liver and hepatitis c among the conditions Dr. Bernstein treats.

CMS data shows 982 Medicare services from Dr. Bernstein across 6 procedure codes in 2024, for 307 Medicare patients. Medicare paid $66,133 for them. Every service was in an office.

CMS counts 307 Medicare patients who saw Dr. Bernstein in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bernstein's median patient age at 61, with 50% women.

In 2024, Dr. Bernstein wrote 340 Medicare Part D claims for 94 patients. 80% of them were for generic drugs. CMS names the drug for 244 of them, across 8 drugs with 11 or more claims each, at $232,376 in total drug cost. In 2023, CMS named 123 claims across 5 drugs.

Dr. Bernstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Bernstein, published from 2013 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Hepacivirus, Antiviral Agents and Drug Therapy, Combination. Dr. Bernstein has published most often in Am J Gastroenterol. Dr. Bernstein's most frequent co-authors are Paul J. Pockros, MD, Eugene R. Schiff, MD and Stuart Akerman, MD.

Dmand AI links Dr. Bernstein to 1 clinical trial. Conditions studied include Hepatitis B, Chronic and Hepadnaviridae Infections.

CMS Open Payments shows 502 general payments to Dr. Bernstein from 27 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Intercept Pharmaceuticals, Inc. paid the most, $135,516. It also lists 2 research payments totaling $1,532 from 2016 to 2018.

Dmand AI lists 5 awards for Dr. Bernstein, most recently Fellow in 2014.

Dr. Bernstein graduated from Renaissance School of Medicine at Stony Brook University in 1988. Dr. Bernstein is a member of American Association for the Study of Liver Diseases, ACG, ACP, AGA, Bockus International Society of Gastroenterology and Empire Liver Foundation.

Dr. Bernstein is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.